This compound is primarily used in the treatment of advanced basal cell carcinoma, a type of skin cancer. It works by inhibiting the Hedgehog signaling pathway, which is crucial for the growth and proliferation of cancer cells in this condition. By targeting this pathway, it helps to slow down or stop the progression of the disease. It is typically prescribed for patients who are not candidates for surgery or radiation therapy. The compound is administered orally, allowing for convenient patient use. Its effectiveness has been demonstrated in clinical trials, making it a valuable option for managing this specific type of cancer. Regular monitoring is required to manage potential side effects and ensure optimal therapeutic outcomes.